Corifollitropin alfa for poor responders patients, a prospective randomized study

por Fusi, F. M., Zanga, L., Arnoldi, M., Melis, S., Cappato, M., Candeloro, I., Di Pasqua, A.
Publicado 2020

A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR

por Tosco, A, De Gregorio, F, Esposito, S, De Stefano, D, Sana, I, Ferrari, E, Sepe, A, Salvadori, L, Buonpensiero, P, Di Pasqua, A, Grassia, R, Leone, C A, Guido, S, De Rosa, G, Lusa, S, Bona, G, Stoll, G, Maiuri, M C, Mehta, A, Kroemer, G, Maiuri, L, Raia, V
Publicado 2016